> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Iradimed Raises Low End Of Profit Outlook, Cuts Top Of Revenue Range, As Q3 Sales Hit $24.2 Million
- URL: https://www.bullished.co/iradimed-raises-low-end-of-profit-outlook-cuts-top-of-revenue-range-as-q3-sales-hit-24-2-b40956d1/
- Published: 2026-10-30T12:51:14.000Z
- Updated: 2026-10-30T12:51:14.000Z
- Description: The MRI-pump maker's third-quarter revenue rose 14% from a year earlier, while its 2026 revenue range now tops out at $93.1 million.
- Author: Matteo Parrino
- Tags: Earnings, IRMD, Industry: Healthcare

Iradimed, which makes IV pumps and patient monitors built to work safely inside MRI scanners, reported third-quarter [revenue of $24.2 million](https://www.sec.gov/Archives/edgar/data/0001325618/000162828026068454/irmd-2026930xexx991.htm?ref=bullished.co), up 14% from a year earlier, and cut the top of its 2026 revenue and earnings ranges. Net income rose 17% to $6.5 million, the company said Friday.

## Quarter driven by the new 3870 pump

Revenue also climbed 18% from the second quarter. [Diluted earnings per share](https://www.globenewswire.com/news-release/2026/10/30/3392213/32443/en/iradimed-corporation-reports-third-quarter-2026-financial-results.html?ref=bullished.co) were $0.51, against $0.43 a year earlier, and adjusted earnings per share, which exclude stock-based pay, were $0.55 against $0.47.

CEO Roger Susi called it record revenue and credited the continued launch of the new [3870 MR IV](https://www.globenewswire.com/news-release/2026/10/30/3392213/32443/en/iradimed-corporation-reports-third-quarter-2026-financial-results.html?ref=bullished.co) pump. "Quarterly bookings also set new records," he said, with domestic pump channels booked up 45% from a year earlier.

Over 70% of pump bookings were for a "quad stack" of four pumps on one IV pole, which Susi said doubles the pump channels previously available at each MRI as customers replace the older model.

Pump revenue was $8.7 million against $8.3 million a year earlier, while vital signs monitors brought in $8.0 million, up from $6.9 million. Disposables rose to $5.0 million from $4.1 million.

The gross margin was 76%, down from 78% a year earlier. Susi said it improved from the prior quarter as manufacturing gained experience while ramping production. Operating cash flow was $7.0 million, flat with a year earlier.

## A narrower full-year range

For 2026, Iradimed now expects revenue of [$91.6 million](https://wtop.com/national/2026/10/iradimed-q3-earnings-snapshot/?ref=bullished.co) to $93.1 million, from $91.0 million to $96.0 million. Adjusted earnings per share guidance is $2.07 to $2.11, from $2.06 to $2.21, and standard diluted EPS guidance is $1.90 to $1.94, from $1.90 to $2.05.

So the low end of revenue and adjusted EPS rose slightly, the low end of standard EPS held, and every top end fell.

For the fourth quarter, [the company expects](https://wtop.com/national/2026/10/iradimed-q3-earnings-snapshot/?ref=bullished.co) revenue of $25.0 million to $26.5 million and adjusted EPS of $0.57 to $0.61\. Susi said that would reach a $100.0 million revenue run rate.

## Cash, dividend and the business

Iradimed sells its MRidium infusion pumps and monitors mainly to hospitals. Fiscal 2025 revenue was $83.8 million. For the first nine months of 2026, revenue was $66.6 million, up 9%, and net income was $17.5 million.

Cash stood at $63.3 million on September 30, up from $51.2 million at the end of 2025\. The board declared a $0.20 per-share dividend, payable November 27 to holders of record on November 13.

The fourth-quarter guidance range of $25.0 million to $26.5 million is the next test of the 3870 ramp.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — IRADIMED CORP (IRMD)](https://www.sec.gov/Archives/edgar/data/0001325618/000162828026068454/irmd-20261030.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit irmd-2026930xexx991.htm — IRADIMED CORP 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001325618/000162828026068454/irmd-2026930xexx991.htm?ref=bullished.co) — SEC EDGAR
- [IRadimed: Q3 Earnings Snapshot – WTOP News](https://wtop.com/national/2026/10/iradimed-q3-earnings-snapshot/?ref=bullished.co) — wtop.com
- [IRADIMED CORPORATION Reports Third Quarter 2026 Financial](https://www.globenewswire.com/news-release/2026/10/30/3392213/32443/en/iradimed-corporation-reports-third-quarter-2026-financial-results.html?ref=bullished.co) — globenewswire.com